Devi Sridhar, senior research fellow at the Blavatnik School of Government, explores the challenges and benefits of multi-bi financing in PLOS Medicine this month.
Multi-bi financing is forcing multilateral institutions such as the WHO 'to reflect on how to reform to remain more appealing to the wider set of stakeholders and interests at play'. The risks, however, include a shift in agenda and priority setting towards 'the marketplace of global initiatives', rather than the communities who will live with the choices made.
Read the full article here.
